Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
Titel:
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
Auteur:
Argiris, A. Lee, J.W. Stevenson, J. Sulecki, M.G. Hugec, V. Choong, N.W. Saltzman, J.N. Song, W. Hansen, R.M. Evans, T.L. Ramalingam, S.S. Schiller, J.H.